| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Michael Andreeff | Q66385504 |
| P2093 | author name string | Ann H Klopp | |
| Anshul Gupta | |||
| Frank Marini | |||
| Erika Spaeth | |||
| P2860 | cites work | The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study | Q80471824 |
| A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks | Q81514904 | ||
| A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1 | Q81596726 | ||
| Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays | Q83142880 | ||
| Mesenchymal stem cells enhance growth and metastasis of colon cancer | Q84233035 | ||
| Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts | Q24313549 | ||
| Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs | Q24651962 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury | Q28272621 | ||
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
| Mesenchymal stem cells within tumour stroma promote breast cancer metastasis | Q29614303 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
| Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma | Q30493691 | ||
| Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells | Q31077883 | ||
| Mesenchymal stem cells in early entry of breast cancer into bone marrow | Q33346309 | ||
| Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression | Q33427809 | ||
| Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease. | Q33466454 | ||
| Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. | Q33483354 | ||
| A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype | Q33570359 | ||
| Retracted: Upregulation of PTEN in Glioma Cells by Cord Blood Mesenchymal Stem Cells Inhibits Migration via Downregulation of the PI3K/Akt Pathway | Q33570393 | ||
| Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas | Q33609232 | ||
| Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts | Q33618949 | ||
| Cord Blood Stem Cell-Mediated Induction of Apoptosis in Glioma Downregulates X-Linked Inhibitor of Apoptosis Protein (XIAP) | Q33646687 | ||
| Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells | Q33680909 | ||
| Effects of transplantation of adipose tissue-derived stem cells on prostate tumor | Q33879286 | ||
| Advances in mesenchymal stem cell-mediated gene therapy for cancer. | Q34135233 | ||
| Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging | Q34162598 | ||
| Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice | Q34269619 | ||
| Tolerogenic dendritic cells: cytokine modulation comes of age. | Q34523591 | ||
| Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma | Q36238078 | ||
| Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives | Q36397353 | ||
| Isolation and perivascular localization of mesenchymal stem cells from mouse brain | Q36818251 | ||
| VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma | Q36858190 | ||
| UC blood-derived mesenchymal stromal cells: an overview | Q36961702 | ||
| Therapeutic applications of mesenchymal stromal cells. | Q37006910 | ||
| Mesenchymal stromal cells from umbilical cord blood | Q37066635 | ||
| Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells | Q37134013 | ||
| Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells | Q37176533 | ||
| Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells | Q37233572 | ||
| Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. | Q37234641 | ||
| Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine | Q37348798 | ||
| Cancer-associated fibroblasts and tumor growth--bystanders turning into key players | Q37390989 | ||
| Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model | Q37455627 | ||
| Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas | Q37461117 | ||
| Epithelial-mesenchymal transition in cancer development and its clinical significance | Q37644546 | ||
| PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival | Q38347797 | ||
| Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness | Q39668916 | ||
| Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment | Q39727653 | ||
| Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation | Q39745012 | ||
| Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). | Q39750162 | ||
| Tissue-resident stem cells promote breast cancer growth and metastasis | Q39889281 | ||
| Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line | Q39901400 | ||
| Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | Q39910399 | ||
| Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. | Q39917835 | ||
| Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo | Q39975853 | ||
| Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells | Q39976240 | ||
| Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model | Q39998770 | ||
| CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells | Q40024053 | ||
| The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo | Q40039805 | ||
| Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice | Q40052794 | ||
| Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells | Q40216419 | ||
| Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo | Q40363908 | ||
| Interactions between human mesenchymal stem cells and natural killer cells | Q40385365 | ||
| Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix | Q40617695 | ||
| Adipose tissue-derived stem cells promote prostate tumor growth | Q42371786 | ||
| White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models | Q42826900 | ||
| Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins | Q44117862 | ||
| Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo | Q44401503 | ||
| Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. | Q45896896 | ||
| Mesenchymal stem cells induce apoptosis of activated T cells | Q46622786 | ||
| Cytokine interactions in mesenchymal stem cells from cord blood | Q46867746 | ||
| Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms | Q47248012 | ||
| Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling | Q47620825 | ||
| Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification | Q47745191 | ||
| Isolation of human adipose-derived stem cells from biopsies and liposuction specimens | Q47814867 | ||
| Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs). | Q48455015 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Isolation and characterization of stem cells from the human parathyroid gland | Q50335588 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. | Q51035411 | ||
| Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 | ||
| Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. | Q52575669 | ||
| Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. | Q53301733 | ||
| Spontaneous human adult stem cell transformation. | Q53358878 | ||
| Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. | Q53390457 | ||
| Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. | Q54498583 | ||
| Spontaneous Malignant Transformation of Human Mesenchymal Stem Cells Reflects Cross-Contamination: Putting the Research Field on Track - Letter | Q61039117 | ||
| Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis | Q61053578 | ||
| Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals | Q62083511 | ||
| Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors | Q64378688 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Mesenchymal stem cells | Q75301443 | ||
| Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice | Q77838827 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplasm | Q1216998 |
| mesenchymal stem cell transplantation | Q67591222 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 11-19 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? | |
| P478 | volume | 29 |
| Q57823570 | A Light-Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo-Photothermal Therapy of Triple Negative Breast Cancer |
| Q39030703 | A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression |
| Q37117174 | A20 plays a critical role in the immunoregulatory function of mesenchymal stem cells |
| Q57284052 | ATP promotes immunosuppressive capacities of mesenchymal stromal cells by enhancing the expression of indoleamine dioxygenase |
| Q38849467 | Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer |
| Q26824871 | Adipose-derived stem cells: selecting for translational success |
| Q35037638 | Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells |
| Q37294943 | Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. |
| Q50228598 | An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma |
| Q39157236 | Analysis of Proliferation of Melanoma Cells and Mesenchymal Stem Cells in Co-Culture and Contribution of Experimental Conditions into Interpretation of the Results |
| Q34990410 | Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-β and treatment with cisplatin in a xenograft mouse model for canine melanoma. |
| Q37119310 | Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and immune responses |
| Q33975595 | Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model |
| Q92134661 | Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells on Tumor Growth and Progression |
| Q34950295 | Bone Marrow-derived Cell Therapy for Oral Mucosal Repair after Irradiation |
| Q35588431 | Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system |
| Q53508987 | Bone marrow-derived mesenchymal stem cells attenuate phosgene-induced acute lung injury in rats. |
| Q52679939 | Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T-cell immune responses via PD-1/PD-L1 pathway. |
| Q36998711 | Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors |
| Q39439676 | Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo |
| Q91999106 | Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities |
| Q39823181 | Breast cancer carcinoma-associated fibroblasts differ from breast fibroblasts in immunological and extracellular matrix regulating pathways. |
| Q47122926 | CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma |
| Q30660784 | CDH1 and IL1-beta expression dictates FAK and MAPKK-dependent cross-talk between cancer cells and human mesenchymal stem cells. |
| Q41191186 | CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice. |
| Q64054231 | CXCR7 signaling promotes breast cancer survival in response to mesenchymal stromal stem cell-derived factors |
| Q37369478 | Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs). |
| Q89725963 | Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives |
| Q38226664 | Cells as delivery vehicles for cancer therapeutics |
| Q38803932 | Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma |
| Q34465378 | Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition |
| Q58804653 | Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise |
| Q52654664 | Conditioned medium from mesenchymal stem cells enhances the migration of hepatoma cells through CXCR4 up-regulation and F-actin remodeling. |
| Q35205677 | Could cancer and infection be adverse effects of mesenchymal stromal cell therapy? |
| Q26744516 | Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids |
| Q34562845 | Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression |
| Q39265654 | Decidua mesenchymal stem cells migrated toward mammary tumors in vitro and in vivo affecting tumor growth and tumor development |
| Q33795203 | Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes |
| Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
| Q43117791 | Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells |
| Q45787651 | Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors. |
| Q92135303 | Differential Response of Non-cancerous and Malignant Breast Cancer Cells to Conditioned Medium of Adipose tissue-derived Stromal Cells (ASCs) |
| Q38925583 | Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. |
| Q33750137 | Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme |
| Q39167876 | Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer |
| Q90751050 | Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation |
| Q37694235 | Effect of Transplantation of Bone Marrow Derived Mesenchymal Stem Cells and Platelets Rich Plasma on Experimental Model of Radiation Induced Oral Mucosal Injury in Albino Rats |
| Q42586818 | Effect of human Wharton's jelly mesenchymal stem cell secretome on proliferation, apoptosis and drug resistance of lung cancer cells |
| Q50100365 | Effect, Feasibility, and Clinical Relevance of Cell Enrichment in Large Volume Fat Grafting: A Systematic Review |
| Q38243325 | Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth |
| Q89697297 | Establishment and Characterization of a Brca1-/-, p53-/- Mouse Mammary Tumor Cell Line |
| Q35082888 | Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells |
| Q28468628 | Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells |
| Q27009438 | Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases? |
| Q47148289 | Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells. |
| Q37686456 | First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial |
| Q38133556 | From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier? |
| Q37989191 | From tendon to nerve: an MSC for all seasons |
| Q38262019 | Gene-directed enzyme prodrug therapy |
| Q38696750 | Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer |
| Q39197693 | Gut Mesenchymal Stromal Cells in Immunity |
| Q38857484 | Harnessing mesenchymal stem cell homing as an anticancer therapy |
| Q38826311 | Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death |
| Q33778236 | Homologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106 |
| Q54246221 | Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice. |
| Q35592434 | Human Mesenchymal Stromal Cells Transplantation May Enhance or Inhibit 4T1 Murine Breast Adenocarcinoma through Different Approaches |
| Q37633231 | Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells |
| Q35035492 | Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion |
| Q36668099 | Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. |
| Q34056467 | Human marrow stromal cells downsize the stem cell fraction of lung cancers by fibroblast growth factor 10. |
| Q38783878 | Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro. |
| Q33455061 | Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues |
| Q35007600 | Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. |
| Q37692723 | Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts. |
| Q37718845 | Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro |
| Q35061366 | Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance |
| Q34043094 | Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor. |
| Q36557205 | IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production |
| Q34566168 | IL-6 secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells |
| Q35456178 | Identification and characterization of unique tumoricidal genes in rat umbilical cord matrix stem cells |
| Q64252398 | Identification of Prognostic and Predictive Osteosarcoma Biomarkers |
| Q27332209 | Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion |
| Q33968361 | Immuno-therapy with anti-CTLA4 antibodies in tolerized and non-tolerized mouse tumor models. |
| Q92698365 | In Reply |
| Q92134808 | In Vitro Assessment of Cytokine Expression Profile of MCF-7 Cells in Response to hWJ-MSCs Secretome |
| Q37121604 | In Vivo therapeutic potential of mesenchymal stem cell-derived extracellular vesicles with optical imaging reporter in tumor mice model |
| Q45873352 | In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging |
| Q35149319 | Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma. |
| Q51095214 | Influence of Mesenchymal Stem Cells Conditioned Media on Proliferation of Urinary Tract Cancer Cell Lines and Their Sensitivity to Ciprofloxacin. |
| Q41872390 | Injured Nerve Regeneration using Cell-Based Therapies: Current Challenges |
| Q28074526 | Interaction of MSC with tumor cells |
| Q53486125 | Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization. |
| Q92669797 | Kinins in Glioblastoma Microenvironment |
| Q37641570 | Lysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis |
| Q38787765 | MSCs and inflammation: new insights into the potential association between ALCL and breast implants |
| Q57293797 | MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway |
| Q57174410 | Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour |
| Q93147053 | Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate |
| Q38983878 | Mesenchymal Stem Cell Treatment of Inflammation-Induced Cancer |
| Q26773413 | Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression |
| Q90056972 | Mesenchymal Stem Cells Beyond Regenerative Medicine |
| Q27305351 | Mesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β |
| Q26770002 | Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression |
| Q95725580 | Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity |
| Q38938230 | Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas |
| Q34429538 | Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis |
| Q38981228 | Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells |
| Q27007499 | Mesenchymal stem cell secretome and regenerative therapy after cancer |
| Q35774310 | Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears |
| Q38543181 | Mesenchymal stem cell-based gene therapy: A promising therapeutic strategy |
| Q28069543 | Mesenchymal stem cell-based therapy in kidney transplantation |
| Q33597555 | Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation |
| Q33738840 | Mesenchymal stem cell-derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells |
| Q38670442 | Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases |
| Q36878769 | Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression |
| Q38736947 | Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells |
| Q26853374 | Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment |
| Q33648915 | Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines |
| Q38062875 | Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets? |
| Q50428041 | Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy |
| Q37945681 | Mesenchymal stem cells in osteoarticular diseases. |
| Q59790772 | Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review |
| Q91297715 | Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges |
| Q36661456 | Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status |
| Q37372102 | Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway |
| Q33850262 | Mesenchymal stem cells inhibited development of lung cancer induced by chemical carcinogens in a rat model |
| Q35313206 | Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model |
| Q92172595 | Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells |
| Q37565450 | Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3. |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q92712104 | Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy |
| Q39113929 | Mesenchymal stem cells: key players in cancer progression |
| Q26796475 | Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt? |
| Q47124715 | Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death |
| Q38014753 | Mesenchymal stromal cells (MSCs): science and f(r)iction |
| Q57789114 | Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival |
| Q90683248 | Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression |
| Q41979143 | Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β |
| Q39215411 | Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice |
| Q33864981 | Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells |
| Q41020605 | Mesenchymal stromal cells protect cancer cells from ROS-induced apoptosis and enhance the Warburg effect by secreting STC1 |
| Q39596076 | Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments |
| Q88597093 | MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells |
| Q34674941 | Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo |
| Q26996790 | Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach |
| Q35553117 | Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy |
| Q37133654 | Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3 |
| Q34285282 | Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes |
| Q37266540 | New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy |
| Q96952560 | Next-generation stem cells - ushering in a new era of cell-based therapies |
| Q36127288 | Nuclear receptors as modulators of the tumor microenvironment |
| Q42177775 | Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells. |
| Q38761193 | Opposite Effects of Coinjection and Distant Injection of Mesenchymal Stem Cells on Breast Tumor Cell Growth |
| Q64076288 | Oral mucosal mesenchymal stem cell‑derived exosomes: A potential therapeutic target in oral premalignant lesions |
| Q60248825 | Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-β/Smad2/3 pathway |
| Q37144591 | PTH/SDF-1α cotherapy induces CD90+CD34- stromal cells migration and promotes tissue regeneration in a rat periodontal defect model |
| Q38765403 | Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system. |
| Q52956451 | Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells. |
| Q35399206 | Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling |
| Q36945106 | Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia |
| Q39057246 | Patient-derived xenograft (PDX) models in basic and translational breast cancer research. |
| Q41163628 | Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer |
| Q35390924 | Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells. |
| Q55509415 | Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review). |
| Q33746577 | Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials |
| Q38165928 | Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures |
| Q89140941 | Poly(alkylidenimine) Dendrimers Functionalized with the Organometallic Moiety [Ru(η⁵-C₅H₅)(PPh₃)₂]⁺ as Promising Drugs Against Cisplatin-Resistant Cancer Cells and Human Mesenchymal Stem Cells |
| Q58700371 | Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats |
| Q38015248 | Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells |
| Q34786543 | Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells |
| Q28085238 | Practical Issues with the Use of Stem Cells for Cancer Gene Therapy |
| Q38838411 | Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway? |
| Q47571353 | Promoting effects of adipose-derived stem cells on breast cancer cells are reversed by radiation therapy |
| Q37536928 | Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species. |
| Q42277124 | Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer |
| Q36867662 | Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures |
| Q64100317 | Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer |
| Q39049644 | Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression |
| Q35038949 | Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection |
| Q35163612 | SDF-1 enhances wound healing of critical-sized calvarial defects beyond self-repair capacity |
| Q26742060 | Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy |
| Q36789564 | Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells |
| Q45887518 | Soluble Factors from Human Fetal Bone Marrow-Derived Mesenchymal Stem Cells: Preparation of Conditioned Medium and Its Effect on Tumor Cells |
| Q33768112 | Stem cell therapies for the treatment of radiation-induced normal tissue side effects |
| Q57126998 | Stem cell therapy for faecal incontinence: Current state and future perspectives |
| Q38075149 | Stem cell therapy in veterinary dermatology |
| Q43226492 | Stem cell therapy independent of stemness |
| Q37897102 | Stem cell-based therapy and regenerative approaches to diseases of the respiratory system |
| Q47123705 | Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway |
| Q36776849 | Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia |
| Q54365444 | Suppression of MicroRNA-203 improves survival of rat bone marrow mesenchymal stem cells through enhancing PI3K-induced cellular activation. |
| Q34706869 | Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling |
| Q33834736 | Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma |
| Q37073094 | Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells. |
| Q55155674 | Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight. |
| Q38750240 | TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models |
| Q64241117 | The Different Effects of IFN-β and IFN-γ on the Tumor-Suppressive Activity of Human Amniotic Fluid-Derived Mesenchymal Stem Cells |
| Q97423665 | The Multifaceted Roles of MSCs in the Tumor Microenvironment: Interactions With Immune Cells and Exploitation for Therapy |
| Q91650493 | The Role of Bone-Derived Exosomes in Regulating Skeletal Metabolism and Extraosseous Diseases |
| Q28073691 | The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation |
| Q41843610 | The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer |
| Q38210142 | The current landscape of adipose-derived stem cells in clinical applications |
| Q36998535 | The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis |
| Q42000888 | The dual role of mesenchymal stem cells in tumor progression. |
| Q59793761 | The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks |
| Q39155959 | The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy |
| Q92260888 | The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model |
| Q47314287 | The key role of extracellular vesicles in the metastatic process. |
| Q36972016 | The metastasis-promoting roles of tumor-associated immune cells |
| Q39012031 | The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies. |
| Q35931795 | The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells |
| Q26823870 | The role of mesenchymal stem cells in cancer development |
| Q38788475 | The role of mesenchymal stem cells in oncology and regenerative medicine |
| Q38151262 | The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma. |
| Q36998634 | The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch? |
| Q41203150 | Therapeutic Potential of Mesenchymal Stem Cells on Early and Late Experimental Hepatic Schistosomiasis Model |
| Q35861702 | Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis |
| Q34741694 | Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth |
| Q37093530 | To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells |
| Q52649741 | Transplantation of placenta-derived multipotent cells in rats with dimethylhydrazine-induced colon cancer decreases survival rate. |
| Q48513627 | Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study |
| Q24630783 | Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes |
| Q39143427 | Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma. |
| Q37007509 | Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. |
| Q45876898 | Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. |
| Q36194212 | Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion. |
| Q39307587 | Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice |
| Q41402133 | Tumor-driven Molecular Changes in Human Mesenchymal Stromal Cells |
| Q42654111 | Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype. |
| Q93386901 | Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer? |
| Q34811043 | Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth |
| Q40536168 | Umbilical cord mesenchymal stem cell-conditioned media prevent muscle atrophy by suppressing muscle atrophy-related proteins and ROS generation. |
| Q92837650 | Upregulation of MiR-29b contributes to mesenchymal stem cell dysfunction in patients with severe pre-eclampsia |
| Q38730790 | Use of genetically engineered stem cells for glioma therapy |
| Q40739842 | Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment |
| Q51279009 | Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer. |
Search more.